XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 65 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. Six UCL scientists elected Fellows of the Royal Society | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2018/may/six-ucl-scientists-elected-fellows-royal-society

    10 May 2018: Six scientists from the UCL community have been elected as Fellows of the Royal Society in recognition of their outstanding contributions to research and innovation that benefit humanity.

    Six scientists from the UCL community have been elected as Fellows of the Royal Society in recognition of their outstanding contributions to research and innovation that benefit humanity.

  2. From rural India to a cutting-edge cancer lab | UCL Cancer Institute…

    https://www.ucl.ac.uk/cancer/news/2018/apr/rural-india-cutting-edge-cancer-lab

    24 Apr 2018: When UCL researcher Dr Raju Veeriah met Indian Prime Minister Nahendra Modi, at the Francis Crick Institute last week, everyone in his home village in India came out in celebration to mark the event.

    When UCL researcher Dr Raju Veeriah met Indian Prime Minister Nahendra Modi, at the Francis Crick Institute last week, everyone in his home village in India came out in celebration to mark the event.

  3. Prostate MRI scans increase cancer detection & reduce…

    https://www.ucl.ac.uk/cancer/news/2018/prostate-cancer-mri-biopsy

    19 Mar 2018: A large international study led by UCL and UCLH researchers, has found that an MRI scan and targeted prostate biopsies, are significantly better at making a positive prostate cancer diagnosis than standard biopsies.

    A large international study led by UCL and UCLH researchers, has found that an MRI scan and targeted prostate biopsies, are significantly better at making a positive prostate cancer diagnosis than standard biopsies.

  4. UCL cancer trials to get £9m funding boost | UCL Cancer Institute -…

    https://www.ucl.ac.uk/cancer/news/2018/cruk-ucl-cancer-trials-centre-funding-award-2018

    15 Feb 2018: Cancer Research UK is planning to invest nearly £9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a £45 million investment into Cancer Research UK’s network of clinical

    Cancer Research UK is planning to invest nearly £9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a £45 million investment into Cancer Research UK’s network of clinical

  5. UCL awarded £1m for major research project on rare cancer | UCL…

    https://www.ucl.ac.uk/cancer/news/2018/tom-prince-trust-donation-osteosarcoma-project

    14 Feb 2018: A UK wide research network for osteosarcoma, a rare type of bone cancer primarily affecting teenagers and young adults, is to be set up by UCL, led by Professor Adrienne Flanagan, thanks to a generous gift of £1m from The Tom Prince Cancer Trust.

    A UK wide research network for osteosarcoma, a rare type of bone cancer primarily affecting teenagers and young adults, is to be set up by UCL, led by Professor Adrienne Flanagan, thanks to a generous gift of £1m from The Tom Prince Cancer Trust.

  6. One cigarette a day increases cardiovascular risk | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2018/no-safe-level-of-smoking

    25 Jan 2018: Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day – concludes a new study published in the BMJ today.

    Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day – concludes a new study published in the BMJ today.

  7. Tumour Heterogeneity Team wins Cancer Research UK Translational…

    https://www.ucl.ac.uk/cancer/news/tumour-heterogeneity-team-win-cruk-translational-cancer-research-prize-2017

    11 Dec 2017: The Tumour Heterogeneity Team, led by Professor Charles Swanton, has been awarded the Cancer Research UK Translational Research Prize at the National Cancer Research Institute (NCRI) conference 2017.

    The Tumour Heterogeneity Team, led by Professor Charles Swanton, has been awarded the Cancer Research UK Translational Research Prize at the National Cancer Research Institute (NCRI) conference 2017.

  8. Experimental model to study the development of brain cancer in…

    https://www.ucl.ac.uk/cancer/news/experimental-model-development-brain-cancer-children

    31 Oct 2017: Researchers from UCL, the German Center for Neurodegenerative Diseases (DZNE) and McGill University, Montreal have published details of a novel laboratory model that replicates the hallmarks of paediatric brain cancer. The research results,

    Researchers from UCL, the German Center for Neurodegenerative Diseases (DZNE) and McGill University, Montreal have published details of a novel laboratory model that replicates the hallmarks of paediatric brain cancer. The research results,

  9. First patient treated with microscopic beads pre-loaded with a…

    https://www.ucl.ac.uk/cancer/news/first-patient-treated-beads-targeted-cancer-drug

    11 Oct 2017: Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc have begun the first clinical trial of an experimental treatment for liver cancer using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug

    Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc have begun the first clinical trial of an experimental treatment for liver cancer using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug

  10. Rucaparib boosts progression-free survival in recurrent ovarian…

    https://www.ucl.ac.uk/cancer/news/rucaparib-boosts-progression-free-survival-ovarian-cancer

    1 Oct 2017: The highly anticipated results from the ARIEL3 clinical trial, evaluating use of rucaparib among women with advanced ovarian cancer, have been published in The Lancet. According to study data, maintenance therapy with rucaparib (Rubraca, Clovis

    The highly anticipated results from the ARIEL3 clinical trial, evaluating use of rucaparib among women with advanced ovarian cancer, have been published in The Lancet. According to study data, maintenance therapy with rucaparib (Rubraca, Clovis

Pagination

Refine

Subjects

Organisational Units

Communication types

Audiences : all → all users